Photoelectron Corp. (PECN) Stock Analysis
DELISTED 2025
What happened to Photoelectron Corp. (PECN) stock?
Photoelectron Corp. (PECN) no longer trades on public markets. It was delisted in October 2025. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Photoelectron Corp. (PECN) trades at $0.00001. Photoelectron Corporation develops, manufactures, and markets miniature x-ray systems for diverse healthcare and non-healthcare applications. These micro-adaptive x-ray systems are utilized for various medical therapies and industrial instrumentation, supplied through OEMs. Sector: Healthcare.
Last analyzed: Jun 15, 2026Analyst Coverage for PECN: PECN does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates PECN against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
PECN: this read rests on a single discipline (Legends Council) — the other council disciplines have no scored data yet.
How is this calculated? →Photoelectron Corp. (PECN) Healthcare & Pipeline Overview
Photoelectron Corporation specializes in developing and manufacturing miniature x-ray systems for a broad spectrum of applications. Serving both healthcare and industrial markets through OEMs, the company's micro-adaptive x-ray technology supports areas like radiation therapy, x-ray fluorescence analysis, and instrumentation, positioning it within the specialized medical device and industrial technology sectors.
What Is the Investment Thesis for PECN?
Photoelectron Corporation (PECN) operates in the specialized miniature x-ray systems market, serving both healthcare and industrial sectors through an OEM model. The company's value proposition is rooted in its proprietary micro-adaptive x-ray technology, which addresses critical needs in applications such as intravascular radiation therapy, brachytherapy, and x-ray fluorescence analysis. A primary growth catalyst is the ongoing demand for advanced, compact imaging and therapeutic solutions in healthcare, driven by an aging global population and technological advancements in minimally invasive procedures. The industrial application segment also presents opportunities, particularly in quality control and material analysis. However, PECN's current market capitalization of $0.00 billion and its listing on the OTC Other market tier indicate significant liquidity and disclosure risks. The extremely high negative Beta of -21.36 suggests an unusual and potentially unreliable correlation with market movements, warranting extreme caution. Future growth will depend on successful product development, regulatory approvals in medical applications, and securing new OEM partnerships. Investors must consider the substantial risks associated with its OTC status, limited financial transparency, and the highly specialized, competitive nature of its market.
Based on FMP financials and quantitative analysis
PECN Key Highlights
Market Capitalization: $0.00 billion, indicating a micro-cap status with potential for high volatility and limited liquidity.
- Beta: -21.36, an exceptionally high negative value suggesting an inverse and highly volatile relationship with the broader market, which is statistically unusual.
- Headquarters: North Billerica, US, establishing its operational base within a key technology and healthcare innovation hub.
- Employee Count: 37 employees, reflecting a specialized, lean operational structure focused on R&D and manufacturing of niche x-ray systems.
- Founding Year: 1989, demonstrating over three decades of experience in developing and marketing advanced x-ray technologies.
Who Are PECN's Competitors?
PECN is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CNVIF Conavi Medical Corp. | $0.13 | -1.19% | $11.4M | 66 |
| VPTDF VentriPoint Diagnostics Ltd. | $0.07 | -4.02% | $13.8M | 62 |
| LHDX Lucira Health, Inc. | $0.45 | +0.00% | $18.4M | 64 |
| PLSM PLSM | $3.01 | +4.88% | $19.6M | 60 |
| PYNKF Perimeter Medical Imaging AI, Inc. | $0.27 | -1.08% | $24.6M | 73 |
| RDGL Vivos Inc. | $0.05 | -5.33% | $26.5M | 61 |
| NVYTF Novacyt S.A. | $0.48 | -0.00% | $34.8M | 61 |
| DNAY Codex DNA, Inc. | $1.30 | +8.33% | $38.3M | 68 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are PECN's Key Strengths?
Specialized expertise in miniature x-ray system development and manufacturing.
- Diverse application portfolio across healthcare (radiation therapy, analysis) and industrial markets.
- Established history since 1989, indicating long-term operational experience.
- OEM-focused business model, leveraging partners for market reach.
What Are PECN's Weaknesses?
Extremely small market capitalization ($0.00B) suggesting limited resources and market presence.
- High negative Beta (-21.36), indicating extreme volatility and unusual market correlation.
- Limited employee count (37), potentially restricting scalability and R&D capacity.
- OTC Other listing, implying limited liquidity and disclosure.
What Could Drive PECN Stock Higher?
Development of new micro-adaptive x-ray system applications for evolving medical needs.
- Pursuit of new Original Equipment Manufacturer (OEM) partnerships in both healthcare and industrial sectors.
- Potential for regulatory milestones or approvals for new medical device integrations utilizing PECN's technology.
- Research and development efforts to enhance the performance and miniaturization of x-ray sources.
What Are the Key Risks for PECN?
Significant liquidity risk due to OTC Other listing and extremely low market capitalization.
- High volatility and unpredictable stock performance, as indicated by the exceptionally negative Beta of -21.36.
- Dependence on Original Equipment Manufacturer (OEM) partners for sales and market penetration.
- Intense competition from larger, better-resourced companies in the medical device and industrial technology sectors.
- Regulatory challenges and lengthy approval processes inherent in the medical device industry.
What Are the Growth Opportunities for PECN?
- Growth opportunity 1: Expansion in Targeted Radiation Therapies. Photoelectron Corp.'s micro-adaptive x-ray systems are critical for targeted radiation therapies such as brachytherapy and intraoperative radiation therapy (IORT). The global brachytherapy market is projected to reach approximately $1.5 billion by 2027, driven by increasing cancer incidence and demand for precise, localized treatments. PECN's competitive advantage lies in its miniature, adaptable x-ray sources, which enable less invasive procedures and improved patient outcomes. Expanding partnerships with medical device OEMs specializing in oncology could significantly increase market penetration over the next 3-5 years, capitalizing on the shift towards more personalized and localized cancer treatments.
- Growth opportunity 2: Penetration of X-ray Fluorescence (XRF) Analysis Market. The company's systems are designed for x-ray fluorescence analysis, a non-destructive analytical technique used across various industries for elemental composition analysis. The global XRF market is estimated to be around $1.2 billion and is expected to grow due to increasing demand in environmental monitoring, material science, and quality control. PECN's miniature x-ray sources offer advantages in portability and integration into compact analytical instruments, appealing to OEMs developing next-generation XRF devices. Strategic collaborations in the industrial instrumentation sector could unlock significant revenue streams within a 2-4 year timeframe, leveraging the trend towards smaller, more efficient analytical tools.
- Growth opportunity 3: Advancements in Intravascular Radiation Therapy (IVRT). Photoelectron Corp.'s technology is applicable to intravascular radiation therapy, a specialized treatment for preventing restenosis after angioplasty. While a niche market, advancements in cardiovascular disease treatment and minimally invasive procedures could drive renewed interest. The global interventional cardiology devices market is substantial, exceeding $20 billion, with specific segments for radiation delivery. PECN's miniature x-ray systems could offer a competitive edge by enabling more precise and safer delivery of radiation within blood vessels. Developing next-generation IVRT solutions with key medical device partners could position PECN for growth in this specialized area over the next 5-7 years, contingent on clinical adoption and regulatory support.
- Growth opportunity 4: OEM Partnerships in Specialized Industrial Instrumentation. Beyond healthcare, PECN supplies instrumentation to the industrial market through OEMs. The demand for specialized electronics and compact analytical tools in sectors like manufacturing, aerospace, and defense is consistently growing. The global industrial x-ray inspection systems market alone is projected to reach over $1 billion by 2028. PECN's micro-adaptive x-ray systems provide a unique value proposition for OEMs seeking to integrate advanced, miniature x-ray capabilities into their products for non-destructive testing, quality assurance, and process control. Expanding the network of industrial OEM partners could diversify revenue streams and reduce reliance on the healthcare sector, with potential impact within 2-5 years.
- Growth opportunity 5: Research and Development for Emerging X-ray Applications. Photoelectron Corp.'s core competency in miniature x-ray systems positions it well for exploring new and emerging applications. Continuous R&D into novel uses for its technology, potentially in areas like security screening, advanced imaging for materials science, or even micro-fabrication, could open entirely new market segments. While specific market sizes for these nascent applications are hard to quantify, the overall market for advanced imaging and analytical technologies is vast. Investing in R&D and securing intellectual property in these areas could provide long-term growth avenues (5-10 years), allowing PECN to adapt its core technology to future technological demands and maintain a competitive edge through innovation.
What Are PECN's Competitive Advantages?
- Proprietary miniature x-ray system technology, developed since 1989.
- Specialization in micro-adaptive x-ray systems for niche applications.
- Established relationships with Original Equipment Manufacturers (OEMs) in specific medical and industrial segments.
- Expertise in adapting x-ray systems for diverse and complex market needs.
- Focus on high-precision, compact x-ray solutions for critical applications.
What Does PECN Do?
Photoelectron Corporation, founded in 1989 and headquartered in North Billerica, Massachusetts, is a technology company focused on the innovation, production, and distribution of miniature x-ray systems. Over its history, the company has evolved to create and adapt these specialized x-ray systems for a diverse array of market applications, spanning both the critical healthcare sector and various non-healthcare related industries. Its core offering revolves around micro-adaptive x-ray systems, which are engineered for precision and versatility. Within the medical domain, these systems are designed for applications such as x-ray fluorescence analysis, intravascular radiation therapy, brachytherapy, radiosurgery, and intraoperative radiation therapy. These advanced therapeutic and diagnostic tools are crucial for targeted treatments and precise analytical procedures, reflecting Photoelectron Corporation's commitment to advancing medical technology. Beyond healthcare, the company extends its reach into industrial markets, providing instrumentation through original equipment manufacturers (OEMs). This dual market focus allows Photoelectron Corporation to leverage its proprietary x-ray technology across a broader commercial landscape, catering to specialized needs where compact, high-performance x-ray solutions are essential. The company's business model emphasizes development and manufacturing, supplying its innovative systems to other companies that integrate them into larger products or services. This OEM-centric approach highlights its role as a key technology provider rather than a direct-to-consumer or end-user supplier. With its long-standing presence since 1989, Photoelectron Corporation has established itself as a niche player in the advanced x-ray system market, continuously adapting its technology to meet evolving demands in both medical and industrial sectors.
What Products and Services Does PECN Offer?
- Develops miniature x-ray systems for various applications.
- Manufactures micro-adaptive x-ray systems.
- Markets its x-ray systems to healthcare and non-healthcare sectors.
- Provides systems for x-ray fluorescence analysis.
- Offers technology for intravascular radiation therapy.
- Supplies systems used in brachytherapy and radiosurgery.
- Develops instrumentation for intraoperative radiation therapy.
- Distributes products to industrial and medical markets through Original Equipment Manufacturers (OEMs).
How Does PECN Make Money?
- Designs and engineers proprietary miniature x-ray systems.
- Manufactures specialized x-ray components and complete systems.
- Sells its micro-adaptive x-ray systems directly to Original Equipment Manufacturers (OEMs).
- Generates revenue from sales of its x-ray systems for integration into larger medical devices and industrial instruments.
- Focuses on a B2B model, supporting other companies' product lines with its core technology.
What Industry Does PECN Operate In?
Photoelectron Corporation operates within the highly specialized medical devices industry, specifically focusing on miniature x-ray systems, while also serving industrial markets. The broader medical device sector is characterized by continuous technological innovation, stringent regulatory requirements, and a growing demand for less invasive diagnostic and therapeutic solutions. PECN's micro-adaptive x-ray systems cater to niche applications like brachytherapy and intraoperative radiation therapy, which are part of the expanding oncology and interventional cardiology markets. The competitive landscape includes larger, diversified medical technology companies as well as smaller, specialized firms. PECN differentiates itself through its focus on miniaturization and adaptability, supplying its technology to OEMs. The "growing demand for specialized electronics" mentioned in the AI Insight aligns with the need for compact, high-precision components in both advanced medical equipment and industrial analytical tools. The company's position as an OEM supplier means its success is tied to the product development cycles and market penetration of its partners.
Who Are PECN's Key Customers?
- Original Equipment Manufacturers (OEMs) in the medical device industry.
- OEMs in the industrial instrumentation sector.
- Companies developing products for radiation therapy applications (e.g., brachytherapy, IORT).
- Manufacturers of analytical equipment utilizing x-ray fluorescence.
- Businesses requiring specialized, miniature x-ray sources for integration into their own products.
Company Profile
Photoelectron Corp. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in North Billerica, US. PECN has traded publicly since 1997.
PECN Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests those in the know see value, hinting at positive future developments.
- The community is buzzing about potential new partnerships, creating an optimistic outlook for expansion.
- There's a strong belief that the company is undervalued compared to its peers, making it an attractive buy.
- Positive sentiment is building around the company's innovative approach to a growing market segment.
Bear Case
- Some community members are concerned about increasing competition eroding market share.
- Recent market volatility has created uncertainty around the company's short-term performance.
- There are whispers of potential regulatory hurdles that could impact future operations.
- A segment of the community feels the company's communication strategy is unclear, leading to distrust.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
PECN Latest News
No recent news available for PECN.
PECN OTC Market Information
Photoelectron Corp. (PECN) trades on the OTC Other tier, which represents the lowest tier of the OTC Markets Group's three marketplaces. Unlike companies listed on national exchanges such as NYSE or NASDAQ, which have stringent listing requirements for financial standards, corporate governance, and reporting, OTC Other companies have minimal to no disclosure requirements. This tier is typically for companies that are not willing or able to meet the reporting standards of higher tiers (like OTCQX or OTCQB) or national exchanges, often leading to less publicly available financial information and greater investment risk.
- OTC Tier: OTC Other
- Limited public disclosure and financial transparency.
- Extremely low liquidity and wide bid-ask spreads.
- Potential for price manipulation due to low trading volume.
- Lack of analyst coverage and institutional interest.
- Higher volatility compared to exchange-listed stocks.
- Verify the company's current financial statements and reports, if any are available.
- Research any recent news or press releases from the company.
- Assess the actual market demand for their specialized x-ray systems.
- Investigate the company's management team and their track record.
- Understand the competitive landscape and PECN's market share.
- Evaluate the regulatory environment for medical devices and x-ray systems.
- Scrutinize the company's intellectual property and patent portfolio.
- Founded in 1989, indicating a long operational history.
- Headquartered in North Billerica, US, suggesting a physical presence.
- Specific product offerings (miniature x-ray systems) and market applications.
- Engages in development, manufacture, and marketing, implying active operations.
- Serves both healthcare and industrial markets through OEMs.
PECN Healthcare Stock FAQ
What happened to Photoelectron Corp. (PECN) stock?
Photoelectron Corp. (PECN) no longer trades on public markets. It was delisted in October 2025. The figures below are historical and are not a current quote.
Can I still buy PECN shares?
No. PECN stopped trading on public markets in October 2025, so the shares are not available through a broker. Anything you see quoted for PECN elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before PECN stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Photoelectron Corp.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What are the key growth opportunities for PECN in healthcare?
Photoelectron Corp.'s primary growth opportunities in healthcare stem from the increasing demand for precise, minimally invasive diagnostic and therapeutic solutions. Its miniature x-ray systems are crucial for applications like intravascular radiation therapy, brachytherapy, and intraoperative radiation therapy, all of which are expanding segments within oncology and interventional cardiology.
How does Photoelectron Corp. navigate regulatory approval processes for its medical applications?
Photoelectron Corp. operates as a technology provider to Original Equipment Manufacturers (OEMs) in the medical market. This means that while PECN develops and manufactures the core miniature x-ray systems, the ultimate responsibility for navigating complex regulatory approval processes, such as those from the FDA or EMA, often falls to its OEM partners who integrate PECN's components into their final medical devices.
What are the main risks associated with investing in Photoelectron Corp. (PECN)?
Investing in Photoelectron Corp. (PECN) carries several significant risks, primarily due to its listing on the OTC Other market tier and its financial profile. The company's extremely low market capitalization of $0.00 billion and its OTC status indicate very limited liquidity, making it difficult to buy or sell shares efficiently and potentially exposing investors to wide bid-ask spreads and price manipulation.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available due to OTC Other listing and minimal disclosure requirements. Market capitalization and Beta are unusually low/high, respectively, and should be interpreted with caution. Growth opportunities and catalysts are inferred based on business description and industry context due to lack of specific company guidance.